Skip to content

PTC Therapeutics PTCT US — Total Assets

Similar metrics at other companies

The J.M. Smucker Company logo
SJMUnited States — Total Assets
$15.87B-7.7%
Pilgrim's Pride Corporation logo
PPCU.S. — Total Assets
$7.02B-12.2%
GATX logo
GATXUNITED STATES — Total Assets
$11.2B+57.1%
LAD
LADUnited States — Total Assets
$20.39B+8.1%
Broadridge Financial Solutions logo
BRUNITED STATES — Total Assets
$5.67B+0.8%
McDonald's logo
MCDU.S. — Total Assets
$23.01B+2.0%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: PTC Therapeutics’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's us — total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's US — total assets?
PTC Therapeutics (PTCT) reported US — total assets of $2.53B in Q4 2025.
How has PTC Therapeutics's US — total assets changed year-over-year?
PTC Therapeutics's US — total assets increased by 88.0% year-over-year, from $1.34B to $2.53B.
What does US — total assets mean?
This metric represents the total economic resources controlled by the company that are located or utilized within the United States. It encompasses both tangible and intangible assets, such as inventory, receivables, and regional intellectual property rights. Monitoring this balance provides insight into the scale of the company's US-based operations and the capital intensity required to support its domestic business model.